R
Rallybio Corp
NASDAQ:RLYB
Rallybio Corp
NASDAQ:RLYB
Price:
1.77 USD
-4.84%
Market Closed
Updated:
May 19, 2024
Rallybio Corp
Operating Expenses
|
Rallybio Corp
Operating Expenses Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
R
|
Rallybio Corp
NASDAQ:RLYB
|
Operating Expenses
-$78.9m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Operating Expenses
-$20.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Operating Expenses
-$12.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-11%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Operating Expenses
-$12.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Operating Expenses
-$4.7B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-14%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Operating Expenses
-$7.3B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-19%
|
See Also
What is Rallybio Corp's Operating Expenses?
Operating Expenses
-78.9m
USD
-78.9m
USD
Based on the financial report for Dec 31, 2023, Rallybio Corp's Operating Expenses amounts to -78.9m USD.
What is Rallybio Corp's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-46%
-46%
Over the last year, the Operating Expenses growth was -16%. The average annual Operating Expenses growth rates for Rallybio Corp have been -46% over the past three years .
You don't have any saved screeners yet
